OncoSec Medical Incorporated reported earnings results for the first quarter ended October 31, 2022. For the first quarter, the company reported net loss was USD 8.06 million compared to USD 9.81 million a year ago. Basic loss per share from continuing operations was USD 4.5 compared to USD 5.51 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0003 USD | +50.00% | +50.00% | -.--% |
2023 | Motion for Asset Sale Approved for OncoSec Medical Incorporated | CI |
2023 | Motion for Asset Sale Filed by OncoSec Medical Incorporated | CI |
1st Jan change | Capi. | |
---|---|---|
-.--% | 1.79K | |
+25.69% | 47.9B | |
+46.90% | 41.42B | |
-3.46% | 40.7B | |
-6.20% | 28.92B | |
+9.17% | 25.55B | |
-20.42% | 19.27B | |
+0.17% | 12.15B | |
+28.07% | 12.14B | |
-1.24% | 11.99B |
- Stock Market
- Equities
- ONCSQ Stock
- News OncoSec Medical Incorporated
- OncoSec Medical Incorporated Reports Earnings Results for the First Quarter Ended October 31, 2022